Profil
Anthony M.
Rimac held several financial and administrative positions in various companies, including Director of Financial Planning & Analysis at Aradigm Corp., Vice President of Finance at Artemis Medical, Inc., Chief Financial Officer & Senior Vice President at Aerovance, Inc., Chief Financial Officer at Chrono Therapeutics, Inc., Chief Financial Officer at Adamas Pharmaceuticals LLC, Chief Financial Officer at Aldea Pharmaceuticals, Inc., and Vice President of Finance & Administration at Aesculap, Inc. Rimac also served as the Chief Operating, Financial & Accounting Officer at Sagimet Biosciences, Inc. and Chief Financial Officer at ESCAPE Bio, Inc. Rimac earned an MBA from Santa Clara University and an undergraduate degree from the University of California, Santa Barbara.
Ehemalige bekannte Positionen von Anthony Rimac
| Unternehmen | Position | Ende |
|---|---|---|
| SAGIMET BIOSCIENCES INC. | Finanzdirektor/CFO | 31.01.2024 |
Aldea Pharmaceuticals, Inc.
Aldea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel enzyme activators to enhance the removal of toxic aldehydes | Finanzdirektor/CFO | 01.07.2015 |
| ADAMAS PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 13.08.2014 |
ESCAPE Bio, Inc.
ESCAPE Bio, Inc. BiotechnologyHealth Technology Develops small molecule therapeutics against genetic targets for neurodegenerative disease | Direktor der Forschung - Eigenkapital | - |
Chrono Therapeutics, Inc.
Chrono Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Produces transdermal drug products | Finanzdirektor/CFO | - |
Ausbildung von Anthony Rimac
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Aradigm Corp.
Aradigm Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes products for the treatment and prevention of respiratory diseases | Health Technology |
Artemis Medical, Inc.
Artemis Medical, Inc. Medical SpecialtiesHealth Technology Manufactures, markets and distributes biopsy markers | Health Technology |
Aerovance, Inc.
Aerovance, Inc. Medical DistributorsDistribution Services Develops drugs for respiratory and inflammatory diseases | Distribution Services |
Chrono Therapeutics, Inc.
Chrono Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Produces transdermal drug products | Commercial Services |
Adamas Pharmaceuticals LLC
Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
Aldea Pharmaceuticals, Inc.
Aldea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel enzyme activators to enhance the removal of toxic aldehydes | Health Technology |
Santa Clara University
Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Santa Barbara
University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aesculap, Inc.
Aesculap, Inc. Medical SpecialtiesHealth Technology Manufactures surgical instruments | Health Technology |
Sagimet Biosciences, Inc.
Sagimet Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of infectious diseases | Health Technology |
ESCAPE Bio, Inc.
ESCAPE Bio, Inc. BiotechnologyHealth Technology Develops small molecule therapeutics against genetic targets for neurodegenerative disease | Health Technology |
















